US Cancer Vaccine Market Outlook 2018 announces a new report on "US Cancer Vaccine Market Outlook 2018" which specifically the cancer vaccine market has remained resilient to the global economic crisis in contrast to many life science sectors.
Spread the Word
Listed Under

* US Cancer Vaccine Market
* Healthcare Industry

* Health

* Navi Mumbai - Maharashtra - India

NAVI MUMBAI, India - Feb. 28, 2014 - PRLog -- Feb 28, 2014 : Bharat Book Bureau presents the new report, on 'US Cancer Vaccine Market Outlook 2018'. Cancer Vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. Therapeutic or Treatment vaccines are targeted at treating an existing cancer by strengthening the body’s natural defences against the cancer and the Prophylactic or Preventive vaccines are used to prevent cancer from developing in healthy people. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Consequently, many companies are expected to enter this emerging and highly profitable field of preventing, treating, and potentially curing cancer.

Owing to drying pipelines and increasing pressure from patent expirations, the big pharma companies recognized the vaccine market as a potential resource of investment. Cancer vaccines are known to earn a higher profit than the generic drugs, owing to the nature of the disease and the urgency in the demand for these vaccines.

The US cancer vaccine market was estimated to be worth USD 14 billion in 2012. The market is expected to witness an increase of 1.5 million people being diagnosed with cancer annually. With such a rapid increase in the incidence, the US cancer vaccine market is expected to grow at a CAGR of 10% to surpass USD 20 billion by 2018. The market for cancer vaccine is in its growth stage in the US and has great opportunities for entry. The USA alone accounts for a dominating share of 50% as compared to a combined share of 50% accounted for by Europe and other regions.

“US Cancer Vaccine Market Outlook 2018” research study gives comprehensive insight on following issues related to cancer vaccine market development in US:

* Cancer Incidence & Prevalence
* Cancer Vaccine Market Overview
* Cancer Vaccine Pricing & Reimbursement Policy
* Cancer Vaccine with Orphan Status
* Cancer Vaccine Pipeline by Indication & Phase
* Market Regulations
* Company Overview & Vaccine Pipeline

Table of contents :

1. US Cancer Incidence & Prevalence
1.1 Leading Cancer Incidence
1.2 Incidence by State
1.3 Incidence by Gender
1.4 Incidence by Age Group

2. US Cancer Vaccine Market Outlook
2.1 Cancer Vaccine Market Overview
2.2 Therapeutic & Prophylactic Vaccine Market
2.3 Cancer Vaccine Pricing & Reimbursement Policy
2.4 Cancer Vaccine with Orphan Status
2.5 Cancer Research Funding & Grants

3. US Cancer Vaccine Market Dynamics
3.1 Favorable Market qpgfh Drivers
3.2 Challenges to be Resolved
3.3 Future Growth Opportunities

4. US Cancer Vaccine Pipeline by Indication
4.1 Breast Cancer
4.2 Bladder Cancer
4.3 Colorectal Cancer
4.4 Endometrial Cancer
4.5 Renal Cancer
4.6 Leukaemia
4.7 Lung Cancer
4.8 Skin Cancer
4.9 Non-Hodgkin Lymphoma
4.10 Pancreatic Cancer

For more information kindly visit :

Related link :

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter:
Follow us on linked in :
Our Blog :

Bharat Book Bureau
+91 22 27810772
Source:Bharat Book Bureau
Posted By:*** Email Verified
Tags:US Cancer Vaccine Market, Healthcare Industry
Location:Navi Mumbai - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Bharat Book News
Daily News
Weekly News

Like PRLog?
Click to Share